Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 13Prostatic Neoplasms 11Kidney Neoplasms 6Parkinson Disease 4, Autosomal Dominant Lewy Body 3Wilms Tumor 2Carcinoma, Renal Cell 2Urologic Neoplasms 1Urethral Neoplasms 1Testicular Neoplasms 1Teratoma 1Renal Pelvis and Ureter Urothelial Carcinoma 1Prostate CA 1Prostate Adenocarcinoma 1Pain, Postoperative 1Pain 1Ovarian Germ Cell Cancer 1Oligometastatic Renal Cell Carcinoma 1Neoplasms, Second Primary 1Neoplasms 1Neoplasm Metastasis 1Muscle Invasive Bladder Cancer 1Lung Neoplasms 1Endodermal Sinus Tumor 1Directly Observed Therapy 1Carcinoma, Transitional Cell 1Adenocarcinoma 1Acute Kidney Injury 1

Interventions

Surgical Procedures, Operative 1Drug Therapy 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Directly Observed Therapy × Surgical Procedures, Operative × Genitourinary × Clear all
NCT06350825 2024-04-05

Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients

The First Affiliated Hospital with Nanjing Medical University

Phase 3 Recruiting
200 enrolled
Genitourinary

Prostatic Neoplasms, Directly Observed Therapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡